Distinct efficacy of pegylated-interferon α2a and α2b during treatment of essential thrombocythemia
- PMID: 23400413
- DOI: 10.1007/s12185-013-1288-x
Distinct efficacy of pegylated-interferon α2a and α2b during treatment of essential thrombocythemia
Similar articles
-
Pegylated interferon alpha-2a for essential thrombocythemia during pregnancy: outcome and safety. A case series.Haematologica. 2016 May;101(5):e182-4. doi: 10.3324/haematol.2015.139691. Epub 2016 Jan 27. Haematologica. 2016. PMID: 26819057 Free PMC article. No abstract available.
-
Data-driven analysis of JAK2V617F kinetics during interferon-alpha2 treatment of patients with polycythemia vera and related neoplasms.Cancer Med. 2020 Mar;9(6):2039-2051. doi: 10.1002/cam4.2741. Epub 2020 Jan 28. Cancer Med. 2020. PMID: 31991066 Free PMC article.
-
Cepeginterferon alfa-2b in the treatment of chronic myeloproliferative diseases.Ter Arkh. 2018 Aug 17;90(7):23-29. doi: 10.26442/terarkh201890723-29. Ter Arkh. 2018. PMID: 30701919 Clinical Trial.
-
Pegylated interferon-α2a and ribavirin versus pegylated interferon-α2b and ribavirin in chronic hepatitis C : a meta-analysis.Drugs. 2013 Mar;73(3):263-77. doi: 10.1007/s40265-013-0027-1. Drugs. 2013. PMID: 23436591 Review.
-
Sofosbuvir, ribavirin and pegylated interferon for a daclatasvir-resistent genotype 3 hepatitis C virus: case report and review.Rev Inst Med Trop Sao Paulo. 2019 Feb 14;61:e12. doi: 10.1590/S1678-9946201961012. Rev Inst Med Trop Sao Paulo. 2019. PMID: 30785566 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous